1887

Abstract

is an aerobic, Gram-negative bacillus, which exhibits innate resistance to multiple antibiotics and disinfectants. Although it is a chronic colonizer of the respiratory tract, it may rarely present with fatal necrotizing pneumonia-like features in immunosuppressed individuals, as those with chronic granulomatous disease, or patients with significant pulmonary compromise, like cystic fibrosis.

A 76-year-old male presented with complaints of breathlessness, cough with mucoid expectoration and fever for 3 days. He had a history of coronary artery disease, chronic obstructive pulmonary disease (COPD), diabetes mellitus and hypertension, under treatment. Pulmonary function tests were suggestive of very severe obstruction (FEV1/FVC was 55 %). So, clinical diagnosis of acute exacerbation of COPD was established. Sputum culture grew . The patient was treated with ceftazidime and meropenem along with inhalational bronchodilators and steroids, and showed symptomatic response to therapy.

There is paucity of the literature describing as a potential cause for acute exacerbations in relatively common clinical conditions, such as COPD. This case report highlights the speculation of this rare possibility, thereby alerting a clinician dealing with such cases.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. The Microbiology Society waived the open access fees for this article.
Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.0.000222
2021-04-15
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/acmi/3/4/acmi000222.html?itemId=/content/journal/acmi/10.1099/acmi.0.000222&mimeType=html&fmt=ahah

References

  1. Govan JR, Hughes JE, Vandamme P. Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol 1996; 45:395–407 [View Article][PubMed]
    [Google Scholar]
  2. Lipuma JJ. Update on the Burkholderia cepacia complex. Curr Opin Pulm Med 2005; 11:528–533 [View Article][PubMed]
    [Google Scholar]
  3. Matthaiou DK, Chasou E, Atmatzidis S, Tsolkas P. A case of bacteremia due to Burkholderia cepacia in a patient without cystic fibrosis. Resp Med CME 2011; 4:144–145 [View Article]
    [Google Scholar]
  4. Ledson MJ, Gallagher MJ, Walshaw MJ. Chronic Burkholderia cepacia bronchiectasis in a non-cystic fibrosis individual. Thorax 1998; 53:430–432 [View Article][PubMed]
    [Google Scholar]
  5. Huang CH, Jang TN, Liu CY, Fung CP, Yu KW et al. Characteristics of patients with Burkholderia cepacia bacteremia. J Microbiol Immunol Infect 2001; 34:215–219[PubMed]
    [Google Scholar]
  6. Avgeri SG, Matthaiou DK, Dimopoulos G, Grammatikos AP, Falagas ME. Therapeutic options for Burkholderia cepacia infections beyond co-trimoxazole: a systematic review of the clinical evidence. Int J Antimicrob Agents 2009; 33:394–404 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/acmi/10.1099/acmi.0.000222
Loading
/content/journal/acmi/10.1099/acmi.0.000222
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error